Towards a Clinically Relevant Lentiviral Transduction Protocol for Primary Human CD34(+) Hematopoietic Stem/Progenitor Cells

Por Millington, Michelle, Arndt, Allison, Boyd, Maureen, Applegate, Tanya, Shen, Sylvie
Publicado em 2009

An Infinitely Expandable Cloning Strategy plus Repeat-Proof PCR for Working with Multiple shRNA

Por Mcintyre, Glen John, Groneman, Jennifer Lynne, Tran, Anna, Applegate, Tanya Lynn
Publicado em 2008

96 shRNAs designed for maximal coverage of HIV-1 variants

Por Shen Sylvie, Jaramillo Angel, Yu Yi-Hsin, Groneman Jennifer, Mcintyre Glen, Applegate Tanya
Publicado em 2009-06-01

Sequencing of the Hepatitis C Virus: A Systematic Review

Por Jacka, Brendan, Lamoury, Francois, Simmonds, Peter, Dore, Gregory J., Grebely, Jason, Applegate, Tanya
Publicado em 2013

Multiple shRNA combinations for near-complete coverage of all HIV-1 strains

Por Mcintyre, Glen J, Groneman, Jennifer L, Yu, Yi-Hsin, Tran, Anna, Applegate, Tanya L
Publicado em 2011

A Quantitative Comparison of Anti-HIV Gene Therapy Delivered to Hematopoietic Stem Cells versus CD4+ T Cells

Por Savkovic, Borislav, Nichols, James, Birkett, Donald, Applegate, Tanya, Ledger, Scott, Symonds, Geoff, Murray, John M.
Publicado em 2014

96 shRNAs designed for maximal coverage of HIV-1 variants

Por Mcintyre, Glen John, Groneman, Jennifer Lynne, Yu, Yi-Hsin, Jaramillo, Angel, Shen, Sylvie, Applegate, Tanya Lynn
Publicado em 2009

In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy

Por Applegate, Tanya Lynn, Birkett, Donald John, Mcintyre, Glen John, Jaramillo, Angel Belisario, Symonds, Geoff, Murray, John Michael
Publicado em 2010

A Comparison of Seminal Hepatitis C Virus (HCV) RNA Levels During Recent and Chronic HCV Infection in HIV-Infected and HIV-Uninfected Individuals

Por Bradshaw, Daniel, Lamoury, Francois, Catlett, Beth, Applegate, Tanya L., Mcallister, John, Dore, Gregory J., Matthews, Gail V., Danta, Mark
Publicado no J Infect Dis (2015)

Interferon λ 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample Types

Por Lamoury, François M.J., Bartlett, Sofia, Jacka, Brendan, Hajarizadeh, Behzad, Grebely, Jason, Matthews, Gail V., Dore, Gregory J., Applegate, Tanya L.
Publicado no J Mol Diagn (2015)

Naturally occurring dominant drug resistance mutations occur infrequently in the setting of recently acquired hepatitis C

Por Applegate, Tanya L, Gaudieri, Silvana, Plauzolles, Anne, Chopra, Abha, Grebely, Jason, Lucas, Michaela, Hellard, Margaret, Luciani, Fabio, Dore, Gregory J, Matthews, Gail V
Publicado no Antivir Ther (2014)

HCV reinfection incidence among individuals treated for recent infection

Por Martinello, Marianne, Grebely, Jason, Petoumenos, Kathy, Gane, Edward, Hellard, Margaret, Shaw, David, Sasadeusz, Joe, Applegate, Tanya L, Dore, Gregory J, Matthews, Gail V
Publicado no J Viral Hepat (2017)

Dynamics of HCV RNA levels during acute hepatitis C virus infection

Por Hajarizadeh, Behzad, Grebely, Jason, Applegate, Tanya, Matthews, Gail V, Amin, Janaki, Petoumenos, Kathy, Hellard, Margaret, Rawlinson, William, Lloyd, Andrew, Kaldor, John, Dore, Gregory J
Publicado no J Med Virol (2014)

Dynamic evolution of hepatitis C virus resistance-associated substitutions in the absence of antiviral treatment

Por Eltahla, Auda A., Leung, Preston, Pirozyan, Mehdi R., Rodrigo, Chaturaka, Grebely, Jason, Applegate, Tanya, Maher, Lisa, Luciani, Fabio, Lloyd, Andrew R., Bull, Rowena A.
Publicado no Sci Rep (2017)

Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection

Por Hajarizadeh, Behzad, Lamoury, François MJ, Feld, Jordan J., Amin, Janaki, Keoshkerian, Elizabeth, Matthews, Gail V., Hellard, Margaret, Dore, Gregory J., Lloyd, Andrew R., Grebely, Jason, Applegate, Tanya L.
Publicado no Virol J (2016)

Plasma Interferon-Gamma-Inducible Protein-10 Levels Are Associated with Early, but Not Sustained Virological Response during Treatment of Acute or Early Chronic HCV Infection

Por Feld, Jordan J., Grebely, Jason, Matthews, Gail V., Applegate, Tanya, Hellard, Margaret, Sherker, Alana, Cherepanov, Vera, Petoumenos, Kathy, Yeung, Barbara, Kaldor, John M., Lloyd, Andrew R., Dore, Gregory J.
Publicado em 2013

Virological responses during treatment for recent hepatitis C virus: Potential benefit for ribavirin use in HCV/HIV co-infection

Por Grebely, Jason, Hellard, Margaret, Applegate, Tanya, Petoumenos, Kathy, Yeung, Barbara, Feld, Jordan J., Rawlinson, William, Lloyd, Andrew R., George, Jacob, Kaldor, John M., Dore, Gregory J., Matthews, Gail V.
Publicado no AIDS (2012)

Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach

Por Jacka, Brendan, Bray, Bethany, Applegate, Tanya L, Marshall, Brandon DL, Lima, Viviane Dias, Hayashi, Kanna, DeBeck, Kora, Raghwani, Jayna, Harrigan, P Richard, Krajden, Mel, Montaner, Julio, Grebely, Jason
Publicado no J Viral Hepat (2017)

Potential role for IL28B genotype in treatment decision-making in recent hepatitis C virus infection

Por Grebely, Jason, Petoumenos, Kathy, Hellard, Margaret, Matthews, Gail, Suppiah, Vijayaprakash, Applegate, Tanya, Yeung, Barbara, Marks, Phillipa, Rawlinson, William, Lloyd, Andrew R., Booth, David, Kaldor, John M., George, Jacob, Dore, Gregory J.
Publicado em 2010

The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis

Por Lamoury, François M. J., Jacka, Brendan, Bartlett, Sofia, Bull, Rowena A., Wong, Arthur, Amin, Janaki, Schinkel, Janke, Poon, Art F., Matthews, Gail V., Grebely, Jason, Dore, Gregory J., Applegate, Tanya L.
Publicado no PLoS One (2015)